Modeling ALS and FTD with iPSC-derived neurons

Brain Research

Volumn 1656, Issue , 2017, Pages 88-97

  Lee, Sebum ^a   Huang, Eric J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Amyotrophic lateral sclerosis (ALS); Frontotemporal dementia (FTD); Frontotemporal lobar degeneration (FTLD); Induced pluripotent stem cells (iPSCs)

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; PROGRANULIN; TAR DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; C9ORF72 GENE; DISEASE COURSE; FRONTOTEMPORAL DEMENTIA; GENE; GENE MUTATION; GENETICS; HUMAN; INDUCED PLURIPOTENT STEM CELL; MAPT GENE; META ANALYSIS (TOPIC); NERVE CELL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROGRANULIN GENE; REVIEW; TDP-43 GENE; ANIMAL; PATHOPHYSIOLOGY; PHYSIOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; FRONTOTEMPORAL DEMENTIA; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEURONS;

EID: 84949982801     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.10.003     Document Type: Review

References (72)

1. Alami, N.H., Smith, R.B., Carrasco, M.A., Williams, L.A., Winborn, C.S., Han, S.S., Kiskinis, E., Winborn, B., Freibaum, B.D., Kanagaraj, A., et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 81 (2014), 536–543.
2. Almeida, S., Gascon, E., Tran, H., Chou, H.J., Gendron, T.F., Degroot, S., Tapper, A.R., Sellier, C., Charlet-Berguerand, N., Karydas, A., et al. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 126 (2013), 385–399.
3. Almeida, S., Zhang, Z., Coppola, G., Mao, W., Futai, K., Karydas, A., Geschwind, M.D., Tartaglia, M.C., Gao, F., Gianni, D., et al. Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects. Cell Rep. 2 (2012), 789–798.
4. Amador-Ortiz, C., Lin, W.L., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff-Radford, N.R., Hutton, M.L., Dickson, D.W., TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer׳s disease. Ann. Neurol. 61 (2007), 435–445.
5. Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351 (2006), 602–611.
6. Arambula, J.F., Ramisetty, S.R., Baranger, A.M., Zimmerman, S.C., A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding. Proc. Natl. Acad. Sci. USA 106 (2009), 16068–16073.
7. Ash, P.E., Bieniek, K.F., Gendron, T.F., Caulfield, T., Lin, W.L., Dejesus-Hernandez, M., van Blitterswijk, M.M., Jansen-West, K., Paul, J.W. 3rd, Rademakers, R., et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77 (2013), 639–646.
8. Barmada, S.J., Skibinski, G., Korb, E., Rao, E.J., Wu, J.Y., Finkbeiner, S., Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J. Neurosci. 30 (2010), 639–649.
9. Baumer, D., Hilton, D., Paine, S.M., Turner, M.R., Lowe, J., Talbot, K., Ansorge, O., Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology 75 (2010), 611–618.
10. Bigio, E.H., Motor neuron disease: the C9orf72 hexanucleotide repeat expansion in FTD and ALS. Nat. Rev. Neurol. 8 (2012), 249–250.
11. Bilican, B., Serio, A., Barmada, S.J., Nishimura, A.L., Sullivan, G.J., Carrasco, M., Phatnani, H.P., Puddifoot, C.A., Story, D., Fletcher, J., et al. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc. Natl. Acad. Sci. USA 109 (2012), 5803–5808.
12. Burkhardt, M.F., Martinez, F.J., Wright, S., Ramos, C., Volfson, D., Mason, M., Garnes, J., Dang, V., Lievers, J., Shoukat-Mumtaz, U., et al. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol. Cell Neurosci. 56 (2013), 355–364.
13. Chen, H., Qian, K., Du, Z., Cao, J., Petersen, A., Liu, H., Blackbourn, L.Wt, Huang, C.L., Errigo, A., Yin, Y., et al. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell 14 (2014), 796–809.
14. DeJesus-Hernandez, M., Mackenzie, I.R., Boeve, B.F., Boxer, A.L., Baker, M., Rutherford, N.J., Nicholson, A.M., Finch, N.A., Flynn, H., Adamson, J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72 (2011), 245–256.
15. Deng, H., Gao, K., Jankovic, J., The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol. 10 (2014), 337–348.
16. Devlin, A.C., Burr, K., Borooah, S., Foster, J.D., Cleary, E.M., Geti, I., Vallier, L., Shaw, C.E., Chandran, S., Miles, G.B., Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat. Commun., 6, 2015, 5999.
17. Donnelly, C.J., Zhang, P.W., Pham, J.T., Haeusler, A.R., Mistry, N.A., Vidensky, S., Daley, E.L., Poth, E.M., Hoover, B., Fines, D.M., et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80 (2013), 415–428.
18. Egawa, N., Kitaoka, S., Tsukita, K., Naitoh, M., Takahashi, K., Yamamoto, T., Adachi, F., Kondo, T., Okita, K., Asaka, I., et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl. Med., 4, 2012, 145ra104.
19. Ehrlich, M., Hallmann, A.L., Reinhardt, P., Arauzo-Bravo, M.J., Korr, S., Ropke, A., Psathaki, O.E., Ehling, P., Meuth, S.G., Oblak, A.L., et al. Distinct neurodegenerative changes in an induced pluripotent stem cell model of frontotemporal dementia linked to mutant tau protein. Stem cell Rep. 5 (2015), 83–96.
20. Espuny-Camacho, I., Michelsen, K.A., Gall, D., Linaro, D., Hasche, A., Bonnefont, J., Bali, C., Orduz, D., Bilheu, A., Herpoel, A., et al. Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 77 (2013), 440–456.
21. Farg, M.A., Sundaramoorthy, V., Sultana, J.M., Yang, S., Atkinson, R.A., Levina, V., Halloran, M.A., Gleeson, P.A., Blair, I.P., Soo, K.Y., et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum. Mol. Genet. 23 (2014), 3579–3595.
22. Fenton, T.R., Gout, I.T., Functions and regulation of the 70 kDa ribosomal S6 kinases. Int. J. Biochem. Cell Biol. 43 (2011), 47–59.
23. Fong, H., Wang, C., Knoferle, J., Walker, D., Balestra, M.E., Tong, L.M., Leung, L., Ring, K.L., Seeley, W.W., Karydas, A., et al. Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells. Stem Cell Rep. 1 (2013), 226–234.
24. Gendron, T.F., Belzil, V.V., Zhang, Y.J., Petrucelli, L., Mechanisms of toxicity in C9FTLD/ALS. Acta Neuropathol. 127 (2014), 359–376.
25. Goldman, J.S., Farmer, J.M., Wood, E.M., Johnson, J.K., Boxer, A., Neuhaus, J., Lomen-Hoerth, C., Wilhelmsen, K.C., Lee, V.M., Grossman, M., et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 65 (2005), 1817–1819.
26. Gomez-Deza, J., Lee, Y.B., Troakes, C., Nolan, M., Al-Sarraj, S., Gallo, J.M., Shaw, C.E., Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration. Acta Neuropathol. Commun., 3, 2015, 38.
27. Han, S.S., Williams, L.A., Eggan, K.C., Constructing and deconstructing stem cell models of neurological disease. Neuron 70 (2011), 626–644.
28. Huang, E.J., Zhang, J., Geser, F., Trojanowski, J.Q., Strober, J.B., Dickson, D.W., Brown, R.H. Jr., Shapiro, B.E., Lomen-Hoerth, C., Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions. Brain Pathol. 20 (2010), 1069–1076.
29. Jahromi, A.H., Fu, Y., Miller, K.A., Nguyen, L., Luu, L.M., Baranger, A.M., Zimmerman, S.C., Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1. J. Med. Chem. 56 (2013), 9471–9481.
30. Kiskinis, E., Sandoe, J., Williams, L.A., Boulting, G.L., Moccia, R., Wainger, B.J., Han, S., Peng, T., Thams, S., Mikkilineni, S., et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell 14 (2014), 781–795.
31. Kwiatkowski, T.J. Jr., Bosco, D.A., Leclerc, A.L., Tamrazian, E., Vanderburg, C.R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E.J., Munsat, T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323 (2009), 1205–1208.
32. Lagier-Tourenne, C., Baughn, M., Rigo, F., Sun, S., Liu, P., Li, H.R., Jiang, J., Watt, A.T., Chun, S., Katz, M., et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc. Natl. Acad. Sci. USA 110 (2013), E4530–4539.
33. Lagier-Tourenne, C., Cleveland, D.W., Neurodegeneration: an expansion in ALS genetics. Nature 466 (2010), 1052–1053.
34. Lattante, S., Rouleau, G.A., Kabashi, E., TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. Hum. Mutat. 34 (2013), 812–826.
35. Lee, E.B., Lee, V.M., Trojanowski, J.Q., Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci. 13 (2012), 38–50.
36. Lillo, P., Mioshi, E., Zoing, M.C., Kiernan, M.C., Hodges, J.R., How common are behavioural changes in amyotrophic lateral sclerosis?. Amyotroph. Lateral Scler. 12 (2011), 45–51.
37. Ling, S.C., Polymenidou, M., Cleveland, D.W., Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79 (2013), 416–438.
38. Lomen-Hoerth, C., Anderson, T., Miller, B., The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59 (2002), 1077–1079.
39. Lomen-Hoerth, C., Murphy, J., Langmore, S., Kramer, J.H., Olney, R.K., Miller, B., Are amyotrophic lateral sclerosis patients cognitively normal?. Neurology 60 (2003), 1094–1097.
40. Mackenzie, I.R., Frick, P., Neumann, M., The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol. 127 (2014), 347–357.
41. Mackenzie, I.R., Neumann, M., Baborie, A., Sampathu, D.M., Du Plessis, D., Jaros, E., Perry, R.H., Trojanowski, J.Q., Mann, D.M., Lee, V.M., A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 122 (2011), 111–113.
42. Mackenzie, I.R., Neumann, M., Bigio, E.H., Cairns, N.J., Alafuzoff, I., Kril, J., Kovacs, G.G., Ghetti, B., Halliday, G., Holm, I.E., et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 119 (2010), 1–4.
43. Millecamps, S., Boillee, S., Le Ber, I., Seilhean, D., Teyssou, E., Giraudeau, M., Moigneu, C., Vandenberghe, N., Danel-Brunaud, V., Corcia, P., et al. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J. Med. Genet. 49 (2012), 258–263.
44. Mori, K., Weng, S.M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H.A., Cruts, M., Van Broeckhoven, C., et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 339 (2013), 1335–1338.
45. Mulders, S.A., van den Broek, W.J., Wheeler, T.M., Croes, H.J., van Kuik-Romeijn, P., de Kimpe, S.J., Furling, D., Platenburg, G.J., Gourdon, G., Thornton, C.A., et al. Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc. Natl. Acad. Sci. USA 106 (2009), 13915–13920.
46. Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006), 130–133.
47. Nishimura, A.L., Shum, C., Scotter, E.L., Abdelgany, A., Sardone, V., Wright, J., Lee, Y.B., Chen, H.J., Bilican, B., Carrasco, M., et al. Allele-specific knockdown of ALS-associated mutant TDP-43 in neural stem cells derived from induced pluripotent stem cells. PLoS One, 9, 2014, e91269.
48. Olive, M., Janue, A., Moreno, D., Gamez, J., Torrejon-Escribano, B., Ferrer, I., TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies. J. Neuropathol. Exp. Neurol. 68 (2009), 262–273.
49. Olney, R.K., Murphy, J., Forshew, D., Garwood, E., Miller, B.L., Langmore, S., Kohn, M.A., Lomen-Hoerth, C., The effects of executive and behavioral dysfunction on the course of ALS. Neurology 65 (2005), 1774–1777.
50. Ou, S.H., Wu, F., Harrich, D., Garcia-Martinez, L.F., Gaynor, R.B., Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69 (1995), 3584–3596.
51. Qiu, H., Lee, S., Shang, Y., Wang, W.Y., Au, K.F., Kamiya, S., Barmada, S., Finkbeiner, S., Lui, H., Carlton, C.E., et al. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J. Clin. Invest., 124, 2014.
52. Raitano, S., Ordovas, L., De Muynck, L., Guo, W., Espuny-Camacho, I., Geraerts, M., Khurana, S., Vanuytsel, K., Toth, B.I., Voets, T., et al. Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia. Stem Cell Rep. 4 (2015), 16–24.
53. Renton, A.E., Majounie, E., Waite, A., Simon-Sanchez, J., Rollinson, S., Gibbs, J.R., Schymick, J.C., Laaksovirta, H., van Swieten, J.C., Myllykangas, L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72 (2011), 257–268.
54. Ringholz, G.M., Appel, S.H., Bradshaw, M., Cooke, N.A., Mosnik, D.M., Schulz, P.E., Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65 (2005), 586–590.
55. Rosen, E.Y., Wexler, E.M., Versano, R., Coppola, G., Gao, F., Winden, K.D., Oldham, M.C., Martens, L.H., Zhou, P., Farese, R.V. Jr., et al. Functional genomic analyses identify pathways dysregulated by progranulin deficiency, implicating Wnt signaling. Neuron 71 (2011), 1030–1042.
56. Sareen, D., Gowing, G., Sahabian, A., Staggenborg, K., Paradis, R., Avalos, P., Latter, J., Ornelas, L., Garcia, L., Svendsen, C.N., Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J. Comp Neurol. 522 (2014), 2707–2728.
57. Sareen, D., O׳Rourke, J.G., Meera, P., Muhammad, A.K., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med., 5, 2013, 208ra149.
58. Sephton, C.F., Tang, A.A., Kulkarni, A., West, J., Brooks, M., Stubblefield, J.J., Liu, Y., Zhang, M.Q., Green, C.B., Huber, K.M., et al. Activity-dependent FUS dysregulation disrupts synaptic homeostasis. Proc. Natl. Acad. Sci. USA 111 (2014), E4769–4778.
59. Serio, A., Bilican, B., Barmada, S.J., Ando, D.M., Zhao, C., Siller, R., Burr, K., Haghi, G., Story, D., Nishimura, A.L., et al. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA 110 (2013), 4697–4702.
60. Sposito, T., Preza, E., Mahoney, C.J., Seto-Salvia, N., Ryan, N.S., Morris, H.R., Arber, C., Devine, M.J., Houlden, H., Warner, T.T., et al. Developmental regulation of tau splicing is disrupted in stem cell derived neurons from frontotemporal dementia patients with the 10+16 splice-site mutation in MAPT. Hum. Mol. Genet, 2015.
61. Strong, M.J., Grace, G.M., Freedman, M., Lomen-Hoerth, C., Woolley, S., Goldstein, L.H., Murphy, J., Shoesmith, C., Rosenfeld, J., Leigh, P.N., et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 10 (2009), 131–146.
62. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007), 861–872.
63. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006), 663–676.
64. Toma, J.S., Shettar, B.C., Chipman, P.H., Pinto, D.M., Borowska, J.P., Ichida, J.K., Fawcett, J.P., Zhang, Y., Eggan, K., Rafuse, V.F., Motoneurons derived from induced pluripotent stem cells develop mature phenotypes typical of endogenous spinal motoneurons. J. Neurosci. 35 (2015), 1291–1306.
65. Vance, C., Rogelj, B., Hortobagyi, T., De Vos, K.J., Nishimura, A.L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323 (2009), 1208–1211.
66. Wainger, B.J., Kiskinis, E., Mellin, C., Wiskow, O., Han, S.S., Sandoe, J., Perez, N.P., Williams, L.A., Lee, S., Boulting, G., et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 7 (2014), 1–11.
67. Warf, M.B., Nakamori, M., Matthys, C.M., Thornton, C.A., Berglund, J.A., Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc. Natl. Acad. Sci. USA 106 (2009), 18551–18556.
68. Wheeler, T.M., Leger, A.J., Pandey, S.K., MacLeod, A.R., Nakamori, M., Cheng, S.H., Wentworth, B.M., Bennett, C.F., Thornton, C.A., Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488 (2012), 111–115.
69. Wolfe, M.S., Tau mutations in neurodegenerative diseases. J. Biol. Chem. 284 (2009), 6021–6025.
70. Yan, J., Deng, H.X., Siddique, N., Fecto, F., Chen, W., Yang, Y., Liu, E., Donkervoort, S., Zheng, J.G., Shi, Y., et al. Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia. Neurology 75 (2010), 807–814.
71. Yang, Y.M., Gupta, S.K., Kim, K.J., Powers, B.E., Cerqueira, A., Wainger, B.J., Ngo, H.D., Rosowski, K.A., Schein, P.A., Ackeifi, C.A., et al. A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell 12 (2013), 713–726.
72. Zhang, Z., Almeida, S., Lu, Y., Nishimura, A.L., Peng, L., Sun, D., Wu, B., Karydas, A.M., Tartaglia, M.C., Fong, J.C., et al. Downregulation of microRNA-9 in iPSC-derived neurons of FTD/ALS patients with TDP-43 mutations. PLoS One, 8, 2013, e76055.